ASCO: Targeted RT Treats Certain Advanced Prostate Cancers
MONDAY, June 7, 2021 (HealthDay News) — For previously treated metastatic...
Read More
Hematology/Oncology
ASCO: Targeted RT Treats Certain Advanced Prostate Cancers
MONDAY, June 7, 2021 (HealthDay News) — For previously treated metastatic...
Read More
Bladder Sparing Studied in Muscle-Invasive Bladder Cancer
For patients with muscle-invasive bladder cancer, transurethral resection and combination...
Read More
Bladder Sparing Studied in Muscle-Invasive Bladder Cancer
MONDAY, June 7, 2021 (HealthDay News) — For patients with muscle-invasive bladder cancer,...
Read More
Earlier Screening Urged for Relatives of Prostate Cancer Patients
FRIDAY, June 4, 2021 (HealthDay News) — The optimal age for starting prostate cancer (PCa)...
Read More
Pembrolizumab Ups DFS in High-Risk Resected Clear-Cell RCC
For patients with fully resected intermediate-high-risk or high-risk clear-cell renal cell...
Read More
Adding Olaparib Slows High-Risk Early Breast Cancer
The addition of therapy with the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in an...
Read More
FDA Approves First Targeted Therapy for NSCLC With KRAS Mutations
FRIDAY, June 4, 2021 (HealthDay News) — Lumakras (sotorasib) received the first approval for...
Read More
Mastocytosis and Hymenoptera Venom Allergy Profiled in the U.S.
THURSDAY, June 3, 2021 (HealthDay News) — The prevalence of hymenoptera venom anaphylaxis...
Read More
After Editor-in-Chief’s Resignation, JAMA Journals Outline Steps to Address Racism
THURSDAY, June 3, 2021 (HealthDay News) — Reacting to recent controversy, the American...
Read More
Advanced Ovarian Cancer: Identifying Opportunities for Prehabilitation
Patients with epithelial ovarian cancer most commonly present when their disease has reached an...
Read More
Most Severe Effects of PIMS-TS Resolved at Six Months
WENESDAY, June 2, 2021 (HealthDay News) — Though the need for physical rehabilitation and...
Read More
Delaying Surgery Linked to Worse Outcomes for NSCLC
WEDNESDAY, June 2, 2021 (HealthDay News) — For patients with non-small cell lung cancer...
Read More
Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer.
Ovarian cancer (OvCa) disseminates primarily intraperitoneally. Detached tumor cell aggregates...
Read More
Amphiregulin increases migration and proliferation of epithelial ovarian cancer cells by inducing its own expression via PI3-kinase signaling.
The epidermal growth factor receptor (EGFR) is overexpressed in many types of cancer, including...
Read More
JAMA Journals Editor-in-Chief Steps Down After Deputy’s Racism Comments
TUESDAY, June 1, 2021 (HealthDay News) — Because of controversial statements about racism...
Read More
ASCO: Incidence of Cervical Cancer Has Decreased in the United States
TUESDAY, June 1, 2021 (HealthDay News) — The incidence of cervical cancer has decreased,...
Read More
The Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratios in Predicting Response to Platinum-based Chemotherapy for Epithelial Ovarian Cancer.
The patients with advanced-stage ovarian cancer have higher factors complicating surgery; thus,...
Read More
Sonosensitizer-Functionalized Graphene Nanoribbons for Adhesion Blocking and Sonodynamic Ablation of Ovarian Cancer Spheroids.
Advanced stage ovarian cancer is challenging to treat due to widespread seeding of tumor spheroids...
Read More
Ga-FAPI-PET/CT in patients with various gynecological malignancies.
Ga-FAPI (fibroblast activation protein inhibitor) is a novel and highly promising radiotracer for...
Read More